Doose Syndrome, also known as epilepsy with myoclonic-atonic seizures (EMAtS) or myoclonic-astatic epilepsy (MAE), is a rare form of childhood epilepsy that primarily affects children between 2 and 6 years of age. It accounts for 1% to 2% of epilepsies that begin in childhood.
At DooseSyndrome.com we are dedicated to providing reliable information, support, and updated resources for families affected by this condition.
What is Doose Syndrome?
First described by German neuropediatrician Hermann Doose in the 1970s, Doose Syndrome is a generalized epileptic syndrome characterized by multiple seizure types, especially myoclonic and atonic seizures (sudden falls). Children usually develop normally before seizure onset.
It is considered a developmental epileptic encephalopathy, where seizures can affect cognitive and behavioral development during the active phase.
Symptoms of Doose Syndrome
- Myoclonic-atonic seizures (drop attacks): The most characteristic. Sudden loss of muscle tone causing falls.
- Myoclonic seizures: Brief muscle jerks, especially in arms and head.
- Generalized tonic-clonic seizures: Full convulsions.
- Atypical absences and massive myoclonic seizures.
- Non-convulsive status epilepticus: May appear during the "stormy" phase.
Symptoms usually begin between 2 and 6 years of age, peaking around 3 years. Many children have prior normal development.
Causes & Risk Factors
The exact cause is unknown in most cases, but it is considered genetic in origin. Mutations have been identified in genes such as SCN1A, SCN2A, SYNGAP1, and others. Approximately one third of families have a history of epilepsy or febrile seizures.
It is not directly hereditary, but a genetic predisposition exists.
Diagnosis of Doose Syndrome
Diagnosis is based on:
- Detailed clinical history.
- Electroencephalogram (EEG): Shows characteristic patterns of generalized slow waves and spike-wave/polyspike-wave.
- Normal magnetic resonance imaging (MRI) in most cases.
- Genetic testing (epilepsy panels).
It is important to differentiate it from other syndromes such as Lennox-Gastaut or Dravet syndrome.
Treatment of Doose Syndrome
Treatment is individualized and often requires multiple medications. The most effective options include:
- Valproic acid (often first-line).
- Lamotrigine (at low doses).
- Ethosuximide, benzodiazepines, and levetiracetam.
- Ketogenic diet: Highly effective in refractory cases.
- Vagus nerve stimulation (VNS) or callosotomy in severe cases.
Avoid drugs such as carbamazepine or vigabatrin, which can worsen seizures.
Prognosis & Outcome
The prognosis is variable. Approximately two thirds of children achieve seizure remission (many within 5-7 years after onset). However, mild to moderate cognitive sequelae may occur in some cases.
Early intervention significantly improves outcomes.
References & Authoritative Sources
- Epilepsy Foundation. Myoclonic Atonic Epilepsy (Doose Syndrome). epilepsy.com
- Cincinnati Children's Hospital. Doose Syndrome. cincinnatichildrens.org
- Doose Syndrome Epilepsy Alliance. doosesyndrome.org
- Hinokuma et al. Clinical and genetic characteristics of patients with Doose syndrome. PMC (2020). pmc.ncbi.nlm.nih.gov
- EpilepsyDiagnosis.org. Epilepsy with myoclonic atonic seizures. epilepsydiagnosis.org
This information is educational and does not replace professional medical advice. Always consult a neuropediatrician specialized in epilepsy.